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Abstract – The reaction of aryl isoselenocyanates (1a-d) with 4-(diethyl-
amino)-3-butyn-2-one (6) in refluxing tetrahydrofurane afforded N-
arylselenet-2(2H)-imines (7) in moderate yield. The structure of the stable 
4-bromophenyl derivative (7b) has been established by X-Ray 
crystallography. A stepwise cycloaddition via an intermediate zwitterion 
(A/A′) is proposed as the reaction mechanism. In boiling tetrahydrofurane, 
the selenetimines (7) are in equilibrium with ketenimines (B), which were 
intercepted by amines to give 2-(diaminomethylene)-3-oxobutane 
selenamides of type 8.  
 
 
INTRODUCTION 
 
In the last few years, the attractivity of selenaheterocycles has increased remarkably because of 
their interesting reactivities1 and pharmaceutical applications2 (see also lit. cited in ref.3). As 
many syntheses of selenium-containing heterocycles involve the use of toxic selenium reagents, 
which are often difficult to handle, new synthetic approaches are of high interest. Recently, we 
have shown that isoselenocyanates are convenient precursors for the introduction of selenium 
into heterocycles.3-6 They are easy and relatively cheap to prepare, safe to handle, and less 
toxic. For example, aryl isoselenocyanates (1) react with 3-amino-2-chloropyridine (2) to give 
selenazolo[5,4-b]pyridines (3),3 and with the 2-chloroquinoline derivative (4), 1H-1,3,6-
triazaaceanthrylenes of type 5 are obtained (Scheme 1). 
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Recently, Yoo et al. reported on the reaction of isothiocyanates with ynamines, which led to 
four-membered thiet-2(2H)-imines via a formal [2 + 2] cycloadditon.7 With the aim of preparing 
the analogous selenaheterocycles, we investigated the reaction of 4-(diethylamino)-3-butyn-2-
one (6) with aryl isoselenocyanates (1). 
 
RESULTS AND DISCUSSION 
 
Heating of a solution of equimolar amounts of aryl isoselenocyanates (1a-d) and 4-(diethyl-
amino)-3-butyn-2-one (6) in tetrahydrofurane (THF) under reflux led to the disappearance of 1 
within two hours (TLC). Evaporation of the solvent and treatment of the oily residue with a 
mixture of ethyl acetate, petroleum ether, and methanol gave yellowish crystalline solids, which 
were identified as 3-acetyl-N-aryl-4-(diethylamino)selenet-2(2H)-imines (7a-c) (Scheme 2) on 
the basis of their elemental analyses and spectroscopic data. For example, 7b shows strong IR 
absorptions (KBr) at 1703, 1629, and 1564 cm-1 for C=O, C=N, and C=C bonds, respectively. In 
the 1H-NMR spectrum (CDCl3), the diethylamino group absorbs as two broad signals for two 
CH2N (4.27 and 3.38 ppm) and a triplet at 1.31 ppm (J = 7.1 Hz) for two Me groups. In the 13C-
NMR spectrum, the C=O group appears at 186.1 ppm, which is characteristic of a vinylogous 
amide structure. The sp2-C atoms of the four-membered ring (C(2)-C(4)) absorb as singlets 
between 161.1 and 112.5 ppm together with the C-atoms of the benzene ring. Again, the CH2N 
groups of the diethylamino residue show two triplets at 53.5 and 49.3 ppm, whereas the two Me 
groups absorb as a quartet at 14.2 ppm. In the case of the 4-methoxyphenyl derivative (7d), the 
product could not be crystallized and remained as an intractable glue. 
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Finally, the structure of the selenet-2(2H)-imine (7b) was established unambiguously by X-Ray 
crystallography (Figure 1). The selenete ring is almost planar, and the attached atoms N(2), 
N(4), and C(11) deviate only slightly from this plane. Furthermore, the acetyl group at C(3) is 
almost coplanar with the heterocycle (dihedral angle C(4)-C(3)-C(11)-O(11)  8.5(4)°), whereas 
the benzene ring is twisted out of this plane (dihedral angle C(2)-N(2)-C(5)-C(6) –49.6(3)°). The 
bond lengths involving atoms C(2), C(3), C(4), N(4), and C(11) show a significant π-electron 
delocalization in this region of the molecule. One of the N-ethyl groups is disordered over two 
conformations with the major confirmation I being present in about 71% of the molecules. In the 
major conformation, the diethylamino group is also coplanar with the core heterocycle (dihedral 
angles Se(1)-C(4)-N(4)-C(13a)  –178.5(2)° and C(3)-C(4)-N(4)-C(15)  –177.0(3)°). 
 
  
 
Figure 1. ORTEP plot8 of the molecular structure of the two conformations I (left, 71%) and II 
(right, 29%) of 7b (arbitrary numbering of atoms; 50% probability ellipsoids). 
 
The selenet-2(2H)-imines (7) are formal [2+2] cycloadducts of the starting materials 1 and 6, but 
it is most likely that they are formed by a two-step mechanism (cf. also ref.7). The push-pull 
substituted alkyne (6) undergoes a nucleophilic addition onto the isoselenocyanate (1) to give a 
zwitterionic intermediate of type A/A′ (Scheme 2). Ring closure between the Se atom and the 
keteniminium moiety leads to the formation of the selenete ring. 
 
When solutions of 7 in THF were treated with morpholine or cyclohexylamine at reflux 
temperature, 2-(diaminomethylen)-3-oxobutane selenamides (8) and (9), respectively, were 
obtained in good yields (Scheme 3). In the case of the 4-methoxyphenyl derivative 7d, the 
crude material obtained from the reaction between 1d and 6 was used directly. The structures 
of the 1:1 adducts are supported by elemental analyses, mass spectra, and 13C-NMR spectra. 
Surprisingly, the IR spectra (KBr) do not show a C=O absorption, indicating that the products 
exist in an enolized form, e.g. 8′ and 9′. In the 1H-NMR spectrum, the singlet at ca. 14.5 ppm is 
in agreement with an enol structure involved in an intramolecular hydrogen bond. 
 
A reaction mechanism for the formation of 8 and 9 is proposed in Scheme 3. Electrocyclic ring 
opening of the selenetes (7) leads to the ketenimines of type B. Then, nucleophilic addition of 
amines with these reactive intermediates gives the observed adducts, for which several enol 
structures are conceivable. 
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In conclusion, we have shown that aryl isoselenocyanates (1) undergo a formal [2+2] 
cycloaddition with the ynamine (6) to give selenet-2(2H)-imines (7) in analogy to the reaction 
involving isothiocyanates, which leads to the corresponding thiet-2(2H)-imines.7 
 
EXPERIMENTAL 
 
General remarks. See ref.5a  IR spectra in KBr (cm-1), NMR spectra at 300 (1H) and 75.6 (13C) 
MHz in CDCl3 (ppm), and CI-MS with NH3 (m/z (rel.%)). 
 
Starting materials. The aryl isoselenocyanates (1a-d) were prepared according to the protocol 
described in ref.8 To a stirred solution of the corresponding N-arylformamide (40 mmol) in abs. 
toluene (100 mL) in an ice bath, Et3N (16.2 g, 160 mmol) and Se black powder were added. 
Then, phosgene (30 g of a 20% solution in toluene, 60 mmol) was added slowly within 30 min. 
An exothermic reaction took place. After complete addition, the suspension was heated under 
reflux for 8-10 h (TLC control). The mixture was filtered and washed with several portions of 
toluene, the filtrate was concentrated and fractionated (SiO2 column) using hexane as the 
eluent. Phenyl isoselenocyanate (1a):8 4.84 g (40 mmol) of N-phenylformamide; yield: 3.24 g 
(45%). 4-Bromophenyl isoselenocyanate (1b): 8.00 g (40 mmol) of N-(4-bromophenyl)-
formamide; yield: 6.05 g (58%). 4-Chlorophenyl isoselenocyanate (1c):8 6.22 g (40 mmol) of N-
(4-chlorophenyl)formamide; yield: 4.77 g (55%). 4-Methoxyphenyl isoselenocyanate (1d):8 6.05 
g (40 mmol) of N-(4-methoxyphenyl)formamide; yield: 3.56 g (42%). N-(4-Chlorophenyl)- and N-
(4-bromophenyl)formamide were prepared according to ref.9 by heating the corresponding 
aniline (20 mmol) in 95% formic acid under reflux for 30 min. After workup, the products were 
recrystallized from H2O. N-(4-Methoxyphenyl)formamide was prepared analogously according 
to ref.10 After evaporation of the solvent, the residue was dissolved in AcOEt and the solution 
was washed with 5% aq. NaHCO3 and H2O. The organic layer was dried (MgSO4), the solvent 
evaporated, and the crude product was used without further purification. 4-(Diethylamino)-3-
butyn-2-one (6) was synthesized following the protocol in ref.11 
 
Synthesis of selenet-2(2H)-imines. General procedure. To a stirred solution of 4-
(diethylamino)-3-butyn-2-one (6) in absolute THF under argon, an equimolar amount of the 
respective aryl isoselenocyanate was added, and the mixture was stirred for 2 h under reflux. 
After cooling to rt, the solvent was evaporated under vacuum, and the remaining oil was treated 
with AcOEt/petroleum ether/MeOH. After cooling in an ice bath, yellowish crystals formed within 
3 h. 
 
3-Acetyl-4-(diethylamino)-N-phenylselenet-2(2H)-imine (7a). From 0.44 g (3.2 mmol) of 6 and 
0.60 g (3.3 mmol) of phenyl isoselenocyanate (1a): 0.41 g (41.6%). Yellowish crystals. M.p. 
104-105oC. IR: 3065w, 3000m, 2972s, 2929m, 1706s, 1631s, 1592s, 1558s, 1483m, 1460m, 
1442m, 1391s, 1356s, 1256m, 1201w, 1188w, 1168m, 1157m, 1108w, 1092m, 1072m, 1020m. 
1H-NMR: 7.36-7.00 (m, 5 arom. H); 4.27, 3.38 (2 br. s, 2 CH2N); 2.50 (s, MeCO); 1.31 (t, J = 
7.1, 2 Me). 13C-NMR: 186.0 (s, CO); 161.6, 149.4, 140.1, 112.6 (4s, 1 arom. C, C(2), C(3), 
C(4)); 129.1, 125.0, 121.1 (3d, 5 arom. CH); 53.0, 49.3 (2 br. signals, 2 CH2N); 31.2 (q, MeCO); 
14.2 (q, 2 Me). CI-MS: 323 (100, [M+1]+). Anal. Calcd for C15H18N2OSe: C, 56.08; H, 5.65; N, 
8.72. Found: C, 56.04; H, 5.81: N, 8.70. 
 
3-Acetyl-N-(4-bromophenyl)-4-(diethylamino)selenet-2(2H)-imine (7b). From 0.19 g (1.4 mmol) 
of 6 and 0.37 g (1.4 mmol) of 4-bromophenyl isoselenocyanate (1b): 0.40 g (71.4%). Yellowish 
crystals. M.p. 105-107oC. IR: 2973m, 2932m, 1703s, 1629s, 1564s, 1478s, 1460m, 1443m, 
1390s, 1305m, 1258m, 1186m, 1162m, 1092m, 1070m, 1018w, 1008m. 1H-NMR: 7.43, 6.90 
(AA’BB’, J = 8.7, 4 arom. H); 4.27, 3.38 (2 br. s, 2 CH2N); 2.47 (s, MeCO); 1.31 (t, J = 7.1, 2 
Me). 13C-NMR: 186.1 (s, CO); 161.1, 148.5, 140.7, 118.3, 112.5 (5s, 2 arom. C, C(2), C(3), 
C(4)); 132.2, 122.8 (2d, 4 arom. CH); 53.5, 49.3 (2 br. signals, 2 CH2N); 31.2 (q, MeCO); 14.2 
(q, 2 Me). CI-MS: 401(100, [M+1]+). Anal. Calcd for C15H17BrN2OSe: C, 45.02; H, 4.28; N, 7.00. 
Found: C, 45.08; H, 4.35; N, 6.99. 
 
3-Acetyl-N-(4-chlorophenyl)-4-(diethylamino)selenet-2(2H)-imine (7c). From 0.36 g (2.6 mmol) 
of 6 and 0.60 g (2.8 mmol) of 4-chlorophenyl isoselenocyanate (1c): 0.50 g (54.3%). Yellowish 
crystals. M.p. 103-103.5oC. IR: 3444w, 2973m, 2931m, 1698s, 1620s, 1573s, 1482s, 1445m, 
1393s, 1364m, 1320m, 1259m, 1190m, 1161m, 1139w, 1009m. 1H-NMR: 7.29, 6.95 (AA’BB’, J 
= 8.7, 4 arom. H); 4.30, 4.35 (2 br. s, 2 CH2N); 2.47 (s, MeCO); 1.31 (t, J = 7.1, 2 Me). 13C-
NMR: 186.1 (s, CO); 161.1, 148.0, 140.2, 130.5, 112.5 (5s, 2 arom. C, C(2), C(3), C(4)); 129.2, 
122.4 (2d, 4 arom. CH); 53.3, 49.6 (2 br. signals, 2 CH2N); 31.2 (q, MeCO); 14.2 (q, 2 Me). CI-
MS: 357 (100, [M+1]+). Anal. Calcd for C15H17ClN2OSe: C, 50.65; H, 4.82; N, 7.88. Found: C, 
50.70; H, 4.91; N, 7.85. 
 
3-Acetyl-4-(diethylamino)-N-(4-methoxyphenyl)selenet-2(2H)-imine (7d). From 0.38 g (2.7 
mmol) of 6 and 0.60 g (2.8 mmol) of 4-methoxyphenyl isoselenocyanate (1d): 0.24 g (25%). 
Yellow glue. After chromatography (SiO2, AcOEt/hexane = 1:3), a yellowish glue was obtained, 
which was directly used for the reaction with morpholine. 
 
Reaction of selenet-2(2H)-imines (7) with amines. General Procedure. To a stirred solution 
of 7 in THF, 1.1-2.0 equivalent of morpholine and cyclohexylamine, respectively, were added. 
The mixture was stirred for 30 min under reflux. Then, the solvent was evaporated to dryness, 
and the residue was treated with Et2O to give yellow crystals. 
 
N,N-Diethyl-2-[(morpholin-1-yl)(phenylamino)methylen]-3-oxobutane selenamide (8a). From 0.3 
g (0.93 mmol) of 7a and morpholine: 0.18 g (47.3%). Yellow crystals. M.p. 153-156oC (Et2O). 
IR: 3442m, 3246m, 3193m, 3072m, 2961m, 2923m, 2851m, 1604m, 1546s, 1491s, 1452s, 
1416s, 1359s, 1316s, 1294s, 1262s, 1236s, 1214s, 1190w, 1163m, 1130m, 1112s, 1065m, 
1021m, 1007m. 1H-NMR: 10.01 (br. s, NH); 7.80-6.90 (m, 5 arom. H); 4.10-2.00 (m, 6 CH2); 
2.10 (s, MeCO); 1.30 (t-like, 2 Me). CI-MS: 410 (100, [M+1]+). Anal. Calcd for C19H27N3O2Se: 
C, 55.88; H, 6.66; N, 10.29. Found: C, 55.39; H, 6.64; N, 10.13. 
 
2-{[(4-Bromophenyl)amino](morpholin-1-yl)methylen}-N,N-diethyl-3-oxobutane selenamide (8b). 
From: 0.02 g (0.05 mmol) of 7b and morpholine: 0.02 g (75.0%). Yellow crystals. M.p. 178-
185oC (Et2O). IR: 3427m (br), 3083w, 2967m, 2915m, 2897m, 2852m, 1607s, 1586m, 1536s, 
1486s, 1453s, 1405m, 1367s, 1346s, 1285s, 1269s, 1258s, 1239s, 1188m, 1171m, 1141m, 
1116s, 1089m, 1078m, 1070m. 1H-NMR: 14.48 (s, OH); 7.71, 7.42 (AA’BB’, J = 8.8, 4 arom. H); 
4.07-3.44 (m, 6 CH2); 1.88 (s, MeCO); 1.43, 1.28 (2t, J = 7.2, 2 Me). 13C-NMR: 183.7 (s, CO); 
182.5 (s, CSe); 174.5, 140.2, 117.9, 108.9 (4s, 2 arom. C, C(2), C(1’)); 131.2, 126.0 (2d, 4 
arom. CH); 54.5, 50.0 (2 br. signals, 2 CH2N); 48.0 (t, 2 CH2); 45.4 (t, 2 CH2); 26.8 (q, MeCO); 
13.9, 11.7 (2q, 2 Me). CI-MS: 488 (91, [M+1]+). Anal. Calcd for C19H26BrN3O2Se: C, 46.83; H, 
5.38; N, 8.62. Found: C, 46.77; H, 5.60; N, 8.50. 
N,N-Diethyl-2-{[(4-methoxyphenyl)amino](morpholin-1-yl)methylen}-3-oxobutane selenamide 
(8d). After treating the crude of 7d with excess of morpholine, 0.35 g (30%) of 8d were 
obtained. When the chromatographically purified 7d was treated with morpholine, 17.6% of 8d 
(with respect to 6) were obtained. Yellow crystals. M.p. 177-178oC. IR: 3442m, 2970s, 2924s, 
2854s, 1603s, 1536s, 1454s, 1371s, 1349s, 1295s, 1271s, 1257s, 1237s, 1188m, 1173s, 
1141m, 1114s, 1089m, 1064m, 1030m. 1H-NMR: 14.17 (s, OH); 7.59, 6.87 (AA’BB’, J = 9.0, 4 
arom. H); 3.80 (s, MeO); 4.20-3.42 (m, 6 CH2); 1.89 (s, MeCO); 1.43, 1.28 (2t, J = 7.2, 2 Me). 
13C-NMR: 183.7 (s, CO); 182.0 (s, CSe); 174.5, 157.2, 134.3, 108.1 (4s, 2 arom. C, C(2), C(1’)); 
126.3, 113.6 (2t, 4 arom. CH); 55.4 (q, MeO); 54.6, 50.1 (2 br. signals, 2 CH2N); 48.0 (t, 2 CH2); 
45.4 (t, 2 CH2); 26.6 (q, MeCO); 13.9, 11.7 (2q, 2 Me). CI-MS: 440 (100, [M+1]+). Anal. Calcd 
for C20H29N3O3Se: C, 54.79; H, 6.67; N, 9.58. Found: C, 54.43; H, 6.74; N, 9.39. 
 
2-[(Cyclohexylamino)(phenylamino)methylen]-N,N-diethyl-3-oxobutane selenamide (9a). From 
0.31 g (0.96 mmol) of 7a and cyclohexylamine: 0.12 g (30.0%). Yellow crystals. M.p. 173-174oC 
(Et2O). IR: 3444m, 3263m, 3176m, 2971m, 2932m, 2855s, 1600s, 1569s, 1505s, 1448s, 1376s, 
1351m, 1287s, 1263m, 1247m, 1205m, 1184m, 1152m, 1137m, 1097m. 1H-NMR: 14.64 (s, 
OH); 7.84 (d, J = 7.6, 2 arom. H); 7.40-7.20 (m, 2 arom. H); 7.28 (t-like, 1 arom. H); 5.71 (d, J = 
8.2, NH); 4.00-3.80 (m, CH2); 3.60-3.40 (m, CH2, 1 H of cyclohexyl); 2.70-2.40 (m, 1 H of 
cyclohexyl); 1.86 (s, MeCO); 1.80-1.60 (m, 3 H of cyclohexyl); 1.60-1.05 (m with 2t at 1.40, 1.29, 
2 Me, 6 H of cyclohexyl). 13C-NMR: 182.3 (s, CO); 179.5 (s, CSe); 166.3, 141.6, 105.4 (3s, 1 
arom. C, C(2), C(1’)); 128.2, 124.7, 124.3 (3d, 5 arom. CH); 55.4 (d, CH of cyclohexyl); 47.6, 
42.0 (2t, 2 CH2N); 34.1, 33.8 (2t, 2 CH2); 26.8 (q, MeCO); 25.2, 24.7 (2t, 2 CH2); 13.4, 10.1 (2q, 
2 Me). CI-MS: 422 (8, [M+1]+, 342 (100). Anal. Calcd for C21H31N3OSe: C, 59.99; H, 7.43; N, 
9.99. Found: C, 59.77; H, 7.48; N, 9.87. 
 
2-{[(4-Bromophenyl)amino](cyclohexylamino)methylen}-N,N-diethyl-3-oxobutane selenamide 
(9b). From 0.12 g (0.30 mmol) of 7b and cyclohexyl amine: 0.09 g (64.3%). Yellow crystals. 
M.p. 160-173oC (Et2O). IR: 3420m, 3240m, 3158m, 3096m, 3045w, 2973m, 2931s, 2855s, 
1594s, 1548s, 1505s, 1482s, 1449m, 1400m, 1373s, 1350s, 1315m, 1279s, 1264m, 1186m, 
1155m, 1139m. 1H-NMR: 14.68 (s, OH); 7.78, 7.40 (AA’BB’, J = 8.8, 4 arom. H); 5.57 (d, J = 
8.4, NH); 4.00-3.70 (m, CH2); 3.60-3.30 (m, CH2, 1 H of cyclohexyl); 2.70-2.30 (m, 1H of 
cyclohexyl); 1.86 (s, MeCO); 1.80-1.60 (m, 3 H of cyclohexyl); 1.50-1.10 (m with 2t at 1.42, 1.30, 
2 Me, 6 H of cyclohexyl). 13C-NMR: 182.3 (s, CO); 179.9 (s, CSe); 166.2, 140.7, 117.4, 105.6 
(4s, 2 arom. C, C(2), C(1’)); 131.1, 125.7 (2d, 4 arom. CH); 55.4 (d, CH of cyclohexyl); 47.7, 
42.0 (2t, 2 CH2N); 34.2, 33.8 (2t, 2 CH2); 26.7 (q, MeCO); 25.1, 24.7 (2t, 2 CH2); 13.4, 10.0 (2q, 
Me). CI-MS: 502 (4), 500 (6, [M+1]+), 420 (73), 418 (66), 313 (98), 311 (100). Anal. Calcd for 
C21H30BrN3OSe: C, 50.51; H, 6.06; N, 8.42. Found: C, 50.82: H, 6.29; N, 8.02. 
 
X-Ray Crystal-Structure Determination of 7b (see Table 1 and Figure 1).13 All measurements 
were made on a Nonius KappaCCD diffractometer18 using graphite-monochromated MoKα 
radiation (λ 0.71073 Å) and an Oxford Cryosystems Cryostream 700 cooler. The data collection 
and refinement parameters are given in Table 1 and a view of the molecule is shown in Figure 
1. Data reduction was performed with HKL Denzo and Scalepack.15. The intensities were 
corrected for Lorentz and polarization effects, and an absorption correction based on the multi-
scan method16 was applied. The structure was solved by direct methods using SIR92,17 which 
revealed the positions of all non-hydrogen atoms. One of the N-ethyl groups is disordered over 
two conformations. Two positions were defined for the atoms of this group and the site 
occupation factor of the major conformaton refined to 0.709(6). Similarity restraints were applied 
to the chemically equivalent bond lengths of the disordered region. Neighboring atoms within 
and between each conformation of the disordered group were also restrained to have similar 
atomic displacement parameters. The non-hydrogen atoms were refined anisotropically. All of 
the H-atoms were placed in geometrically calculated positions and refined using a riding model 
where each H-atom was assigned a fixed isotropic displacement parameter with a value equal 
to 1.2Ueq of its parent C-atom (1.5Ueq for the methyl groups). Refinement of the structure was 
carried out on F2 using full-matrix least-squares procedures, which minimized the function 
Σw(Fo2 – Fc2)2. A correction for secondary extinction was applied. Neutral atom scattering 
factors for non-hydrogen atoms were taken from ref.18, and the scattering factors for H-atoms 
were taken from ref.19 Anomalous dispersion effects were included in Fc;20 the values for f ' and 
f " were those of ref.18b The values of the mass attenuation coefficients are those of ref.18c All 
calculations were performed using SHELXL97.21 
 
 
 
Table 1.  Crystallographic Data of Compound (7b) 
 
Crystallized from AcOEt/CH2Cl2/pet. ether/Et2O/MeOH 
Empirical formula C15H17BrN2OSe 
Formula weight [g mol-1] 400.12 
Crystal color, habit yellow, prism 
Crystal dimensions [mm] 0.20 × 0.22 × 0.30 
Temperature [K] 160(1) 
Crystal system triclinic 
Space group P
_
,1 
Z 2 
Reflections for cell determination 18750 
2θ range for cell determination [°] 4 – 60 
Unit cell parameters: a [Å] 7.6710(1) 
 b [Å] 9.9576(2) 
 c [Å] 12.0856(2) 
 α [°] 105.7377(7) 
 β [°] 94.8258(8) 
 γ [°] 112.0784(9) 
 V [Å3] 805.28(2) 
Dx [g cm-3] 1.650 
µ(MoKα) [mm-1] 4.816 
Scan type φ and ω 
2θ(max) [°] 60 
Transmission factors (min, max) 0.328; 0.400 
Total reflections measured 21000 
Symmetry independent reflections 4675 
Reflections with I > 2σ (I) 3859 
Reflections used in refinement 4675 
Parameters refined; restraints 205; 39 
Final: R(F)  [I>2σ(I) reflections] 0.0301 
 wR(F2)  (all data) 0.0734 
Weights: w = [σ 2(Fo2) + (0.0304P)2 + 0.5172P]-1 where P = (Fo2 + 2Fc2) / 3 
Goodness of fit 1.026 
Secondary extinction coefficient 0.014(1) 
Final ∆max /σ 0.001 
∆ρ (max; min) [e Å-3] 0.56; -0.69 
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